title: HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia.
abstract: BACKGROUND
  Cervical cancer incidence is low in Saudi Arabian women, suggesting low prevalence to HPV infection due to environmental, cultural and genetic differences. Therefore, we investigated HPV prevalence and genotype distribution in cervical cancer as well as the association with 9 genetic single nucleotide polymorphisms (SNPs): CDKN1A (p21) C31A, TP53 C72G, ATM G1853A, HDM2 promoter T309G, HDM2 A110G, LIG4 A591G, XRCC1 G399A, XRCC3 C241T and TGFβ1 T10C, presumed to predispose to cancer.
  
  
  METHODS
  One hundred cervical cancer patients (90 squamous cell carcinoma and 10 adenocarcinoma) and 100 age/sex-matched controls were enrolled. SNPs were genotyped by direct sequencing and HPV was detected and typed in tumors using the HPV Linear Array Test.
  
  
  RESULTS
  Eighty-two cases (82%) were positive for HPV sequences. Seven HPV genotypes were present as single infections (16, 18, 31, 45, 56, 59, 73) and five double infections (16/18, 16/39, 16/70, 35/52, 45/59) were detected. Most common genotypes were HPV-16 (71%), 31 (7%), and 18, 45, 73 (4% each). Only XRCC1 SNP was significantly associated with cervical cancer (P=0.02, OD=1.69; 95% CI= 1.06-2.66). However, nested analysis revealed a preponderance of HPV-positivity in patients harboring the presumed risk allele TP53 G (P=0.06). Both XRCC1 and TP53 SNPs tended to deviate from Hardy-Weinberg equilibrium (HWE; P=0.03-0.07).
  
  
  CONCLUSIONS
  HPV prevalence (82%) in cervical cancer is at the lower range of the worldwide estimation (85 - 99%). While XRCC1 G399A was significantly associated with cervical cancer, TP53 G72C showed borderline association only in HPV-positive patients. Deviation from HWE in HPV-positive patients indicates co-selection, hence implicating the combination of HPV and SNPs in cancer predisposition. Thus, SNPs could be more relevant biomarkers of susceptibility to cervical cancer when associated with HPV infection.
authors: Biomedical Physics, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia. galsbeih@kfshrc.edu.sa.
authors: Ghazi
authors: G
authors: Alsbeih
authors: Najla
authors: N
authors: Al-Harbi
authors: Medhat
authors: M
authors: El-Sebaie
authors: Ismail
authors: I
authors: Al-Badawi
references: J Pak Med Assoc. 1999 Jul;49(7):157-61
references: 10599201
references: Int J Cancer. 2011 May 1;128(9):2224-9
references: 20607828
references: Genet Test Mol Biomarkers. 2012 Feb;16(2):95-101
references: 21877955
references: Cell. 2004 Nov 24;119(5):591-602
references: 15550242
references: N Engl J Med. 2002 Apr 11;346(15):1105-12
references: 11948269
references: Int J Gynaecol Obstet. 2004 Jun;85(3):301-8
references: 15145278
references: N Engl J Med. 2003 Feb 6;348(6):518-27
references: 12571259
references: Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):755-61
references: 20200430
references: Nature. 1998 May 21;393(6682):229-34
references: 9607760
references: J Infect Dis. 2010 Dec 15;202(12):1789-99
references: 21067372
references: Int J Gynecol Cancer. 2011 Jul;21(5):907-10
references: 21697680
references: J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
references: 7791229
references: Gynecol Oncol. 2011 Jun 1;121(3):522-6
references: 21353296
references: J Low Genit Tract Dis. 2012 Apr;16(2):106-20
references: 22371041
references: Carcinogenesis. 2006 Dec;27(12):2469-74
references: 16829685
references: J Med Virol. 2012 Feb;84(2):298-305
references: 22170551
references: Saudi Med J. 2003 Nov;24(11):1225-9
references: 14647558
references: Virology. 1991 Sep;184(1):9-13
references: 1651607
references: Ann Saudi Med. 2001 Jan-Mar;21(1-2):92-6
references: 17264603
references: Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1809-14
references: 17009976
references: Mol Cell Biol. 2002 Apr;22(8):2556-63
references: 11909950
references: Nucleic Acids Res. 2005 May 02;33(8):2512-20
references: 15867196
references: Br J Cancer. 2010 May 25;102(11):1657-60
references: 20407442
references: Lancet Oncol. 2010 Nov;11(11):1048-56
references: 20952254
references: Ann Saudi Med. 2007 Jan-Feb;27(1):1-5
references: 17277496
references: Lancet Oncol. 2009 Aug;10(8):772-84
references: 19625214
references: PLoS One. 2012;7(9):e44441
references: 22984511
references: Gynecol Oncol. 2010 Jul;118(1):29-34
references: 20406711
references: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references: 15761078
references: Int J Mol Med. 2007 Nov;20(5):731-41
references: 17912468
references: Int J Gynecol Cancer. 2004 Mar-Apr;14(2):293-303
references: 15086729
references: JAMA. 1994 Jun 15;271(23):1866-9
references: 8196145
references: Lancet. 1999 Mar 13;353(9156):856-7
references: 10093972
references: Clin Microbiol Infect. 2010 Mar;16(3):262-6
references: 19438642
references: Gynecol Oncol. 2013 Feb;128(2):277-81
references: 23200918
references: Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):11-22
references: 14744727
references: J Pathol. 1999 Sep;189(1):12-9
references: 10451482
references: Int J Cancer. 2000 Aug 15;87(4):528-33
references: 10918193